Insights into oral bioavailability enhancement of therapeutic herbal constituents by cytochrome P450 3A inhibition

References

• Adiwidjaja J, Boddy AV, McLachlan AJ. 2020. Potential for pharmacokinetic interactions between Schisandra sphenanthera and bosutinib, but not imatinib: in vitro metabolism study combined with a physiologically-based pharmacokinetic modelling approach. Br J Clin Pharmacol. 86(10):2080–2094.
   PubMed Web of Science ®Google Scholar
• Anakk S, Ku CY, Vore M, Strobel HW. 2003. Insights into gender bias: rat cytochrome P450 3A9. J Pharmacol Exp Ther. 305(2):703–709.
   PubMed Web of Science ®Google Scholar
• Backman JT, Filppula AM, Niemi M, Neuvonen PJ. 2016. Role of cytochrome P450 2C8 in drug metabolism and interactions. Pharmacol Rev. 68(1):168–241.
   PubMed Web of Science ®Google Scholar
• Bi YF, Liu S, Zhang RX, Song FR, Liu ZQ. 2013. Metabolites and metabolic pathways of mesaconitine in rat liver microsomal investigated by using UPLC-MS/MS method in vitro. Yao Xue Xue Bao. 48(12):1823–1828.
   PubMedGoogle Scholar
• Bi Y, Zhuang X, Zhu H, Song F, Liu Z, Liu S. 2015. Studies on metabolites and metabolic pathways of bulleyaconitine A in rat liver microsomes using LC-MS(n) combined with specific inhibitors. Biomed Chromatogr. 29(7):1027–1034.
   PubMed Web of Science ®Google Scholar
• Breimer DD, Schellens JH. 1990. A ‘cocktail’ strategy to assess in vivo oxidative drug metabolism in humans. Trends Pharmacol Sci. 11(6):223–225.
   PubMed Web of Science ®Google Scholar
• Cao YF, Zhang YY, Li J, Ge GB, Hu D, Liu HX, Huang T, Wang YC, Fang ZZ, Sun DX, et al. 2010. CYP3A catalyses schizandrin biotransformation in human, minipig and rat liver microsomes. Xenobiotica. 40(1):38–47.
   PubMed Web of Science ®Google Scholar
• Chatuphonprasert W, Nemoto N, Sakuma T, Jarukamjorn K. 2012. Modulations of cytochrome P450 expression in diabetic mice by berberine. Chem Biol Interact. 196(1–2):23–29.
   PubMed Web of Science ®Google Scholar
• Chen Q, Wu YJ, Cheng NN, Li YL, Wang YM. 2010. Dual effects of extract of Schisandra chinensis Baill on rat hepatic CYP3A. Yao Xue Xue Bao. 45(9):1194–1198.
   PubMedGoogle Scholar
• Chen T, Su W, Yan Z, Wu H, Zeng X, Peng W, Gan L, Zhang Y, Yao H. 2018. Identification of naringin metabolites mediated by human intestinal microbes with stable isotope-labeling method and UFLC-Q-TOF-MS/MS. J Pharm Biomed Anal. 161:262–272.
   PubMed Web of Science ®Google Scholar
• Chen Y, Guo X, Ma Y, Hu X, Peng Y, Zheng J. 2019. Identification of quinone methide intermediate resulting from metabolic activation of icaritin in vitro and in vivo. Chem Res Toxicol. 32(6):969–973.
   PubMed Web of Science ®Google Scholar
• Cheng C, Lin JZ, Li L, Yang JL, Jia WW, Huang YH, Du FF, Wang FQ, Li MJ, Li YF, et al. 2016. Pharmacokinetics and disposition of monoterpene glycosides derived from Paeonia lactiflora roots (Chishao) after intravenous dosing of antiseptic XueBiJing injection in human subjects and rats. Acta Pharmacol Sin. 37(4):530–544.
   PubMed Web of Science ®Google Scholar
• Cheng ZY, Tian X, Gao J, Li HM, Jia LJ, Qiao HL. 2014. Contribution of baicalin on the plasma protein binding displacement and CYP3A activity inhibition to the pharmacokinetic changes of nifedipine in rats in vivo and in vitro. PLoS One. 9(1):e87234.
   PubMed Web of Science ®Google Scholar
• Conney AH. 2003. Induction of drug-metabolizing enzymes: a path to the discovery of multiple cytochromes P450. Annu Rev Pharmacol Toxicol. 1. 43:1–30.
   PubMed Web of Science ®Google Scholar
• Croft KD. 1998. The chemistry and biological effects of flavonoids and phenolic acids. Annals NY Acad Sci. 854(1):435–442.
   PubMed Web of Science ®Google Scholar
• Cui T, Wang Q, Tian X, Zhang K, Peng Y, Zheng J. 2020. Piperine is a mechanism-based inactivator of CYP3A. Drug Metab Dispos. 48(2):123–134.
   PubMed Web of Science ®Google Scholar
• Dai ZR, Ning J, Sun GB, Wang P, Zhang F, Ma HY, Zou LW, Hou J, Wu JJ, Ge GB, et al. 2019. Cytochrome P450 3A enzymes are key contributors for hepatic metabolism of bufotalin, a natural constitute in Chinese medicine Chansu. Front Pharmacol. 10:52.
   PubMed Web of Science ®Google Scholar
• Davydov DR, Halpert JR. 2008. Allosteric P450 mechanisms: multiple binding sites, multiple conformers or both? Expert Opin Drug Met. 4(12):1523–1535.
   PubMed Web of Science ®Google Scholar
• Davydov DR, Yang Z, Davydova N, Halpert JR, Hubbell WL. 2016. Conformational mobility in cytochrome P450 3A4 explored by pressure-perturbation EPR spectroscopy. Biophys J. 110(7):1485–1498.
   PubMed Web of Science ®Google Scholar
• de Wildt SN, Kearns GL, Leeder JS, van den Anker JN. 1999. Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet. 37(6):485–505.
   PubMed Web of Science ®Google Scholar
• Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M, Borges G, Crozier A. 2013. Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal. 18(14):1818–1892.
   PubMed Web of Science ®Google Scholar
• do Nascimento SB, de Lima Nascimento M, de Araújo LL, de Oliveira FM, do Carmo Vieira M, Duarte-Almeida JM, Siqueira JM, da Costa César I, Derendorf H, de Castro WV. 2020. Evaluation of the Effects of Maytenus ilicifolia on the Activities of Cytochrome P450 3A and P-glycoprotein. CDM. 21(4):281–290.
   Web of Science ®Google Scholar
• Ebrahimpour S, Zakeri M, Esmaeili A. 2020. Crosstalk between obesity, diabetes, and Alzheimer’s disease: introducing quercetin as an effective triple herbal medicine. Ageing Res Rev. 62:101095.
   PubMed Web of Science ®Google Scholar
• Ekroos M, Sjögren T. 2006. Structural basis for ligand promiscuity in cytochrome P450 3A4. Proc Natl Acad Sci USA. 103(37):13682–13687.
   PubMed Web of Science ®Google Scholar
• El-Sherbeni AA, El-Kadi AO. 2017. Microsomal cytochrome P450 as a target for drug discovery and repurposing. Drug Metab Rev. 49(1):1–17.
   PubMed Web of Science ®Google Scholar
• Fantoukh OI, Albadry MA, Parveen A, Hawwal MF, Majrashi T, Ali Z, Khan SI, Chittiboyina AG, Khan IA. 2019. Isolation, synthesis, and drug interaction potential of secondary metabolites derived from the leaves of miracle tree (Moringa oleifera) against CYP3A4 and CYP2D6 isozymes. Phytomedicine. 60(2019):153010.
   PubMed Web of Science ®Google Scholar
• Gaudineau C, Beckerman R, Welbourn S, Auclair K. 2004. Inhibition of human P450 enzymes by multiple constituents of the Ginkgo biloba extract. Biochem Bioph Res Co. 318(4):1072–1078.
   PubMed Web of Science ®Google Scholar
• Gay SC, Roberts AG, Halpert JR. 2010. Structural features of cytochromes P450 and ligands that affect drug metabolism as revealed by X-ray crystallography and NMR. Future Med Chem. 2(9):1451–1468.
   PubMed Web of Science ®Google Scholar
• Gellner K, Eiselt R, Hustert E, Arnold H, Koch I, Haberl M, Deglmann CJ, Burk O, Buntefuss D, Escher S, et al. 2001. Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics. 11(2):111–121.
   PubMedGoogle Scholar
• Gonzalez FJ, Song BJ, Hardwick JP. 1986. Pregnenolone 16 alpha-carbonitrile-inducible P-450 gene family: gene conversion and differential regulation. Mol Cell Biol. 6(8):2969–2976.
   PubMed Web of Science ®Google Scholar
• Goodwin B, Redinbo MR, Kliewer SA. 2002. Regulation of cyp3a gene transcription by the pregnane x receptor. Annu Rev Pharmacol Toxicol. 42(1):1–23.
   PubMed Web of Science ®Google Scholar
• Guengerich FP. 1999. Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol. 39(1):1–17.
   PubMed Web of Science ®Google Scholar
• Haines DC, Tomchick DR, Machius M, Peterson JA. 2001. Pivotal role of water in the mechanism of P450BM-3. Biochemistry. 40(45):13456–13465.
   PubMed Web of Science ®Google Scholar
• Hendrikx JJ, Lagas JS, Song JY, Rosing H, Schellens JH, Beijnen JH, Rottenberg S, Schinkel AH. 2016. Ritonavir inhibits intratumoral docetaxel metabolism and enhances docetaxel antitumor activity in an immunocompetent mouse breast cancer model. Int J Cancer. 138(3):758–769.
   PubMed Web of Science ®Google Scholar
• Hou XQ, Song HP, Chen YB, Cheng SY, Fang SH, Zhang JG, Wang Q. 2018. Effects of Bushen-Yizhi formula on age-related inflammation and oxidative stress in senescence-accelerated mice. Mol Med Rep. 17(5):6947–6960.
   PubMed Web of Science ®Google Scholar
• Hu X, Huang W, Yang Y. 2015. Cytochrome P450 isoenzymes in rat and human liver microsomes associate with the metabolism of total coumarins in Fructus cnidii. Eur J Drug Metab Pharmacokinet. 40(4):373–377.
   PubMed Web of Science ®Google Scholar
• Hu ZY, Zhao YS. 2010. Sex-dependent differences in cytochrome P450 3A activity as assessed by midazolam disposition in humans: a meta-analysis. Drug Metab Dispos. 38(5):817–823.
   PubMed Web of Science ®Google Scholar
• Huang W, Xiong YQ, Xia CH, Hu X. 2020. Effects of osthol on activity, mRNA and protein expression of Cyp3a in rats in vivo. Biopharm Drug Dispos. 41(1–2):64–71.
   PubMed Web of Science ®Google Scholar
• Iwata H, Tezuka Y, Kadota S, Hiratsuka A, Watabe T. 2004. Identification and characterization of potent CYP3A4 inhibitors in Schisandra fruit extract. Drug Metab Dispos. 32(12):1351–1358.
   PubMed Web of Science ®Google Scholar
• Jeon SG, Song EJ, Lee D, Park J, Nam Y, Kim JI, Moon M. 2019. Traditional oriental medicines and Alzheimer’s disease. Aging Dis. 10(2):307–328.
   PubMed Web of Science ®Google Scholar
• Ji HY, Liu KH, Lee H, Im SR, Shim HJ, Son M, Lee HS. 2011. Corydaline inhibits multiple cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes. Molecules. 16(8):6591–6602.
   PubMed Web of Science ®Google Scholar
• Jing W, Liu R, Du W, Luo Z, Guo P, Zhang T, Zeng A, Chang C, Fu Q. 2016. Pharmacokinetic and metabolic characteristics of herb-derived khellactone derivatives, a class of anti-HIV and anti-hypertensive: a review. Molecules. 21(3):314.
   PubMed Web of Science ®Google Scholar
• Josephson F. 2010. Drug-drug interactions in the treatment of HIV infection: focus on pharmacokinetic enhancement through CYP3A inhibition. J Intern Med. 268(6):530–539.
   PubMed Web of Science ®Google Scholar
• Jung JW, Choi MR, Kwon YS, Jeong JS, Son M, Kang HE. 2015. Gender differences in corydaline pharmacokinetics in rats. Xenobiotica. 45(5):456–463.
   PubMed Web of Science ®Google Scholar
• Khalilieh SG, Yee KL, Sanchez RI, Fan L, Anderson MS, Sura M, Laethem T, Rasmussen S, van Bortel L, van Lancker G, et al. 2019. Doravirine and the potential for CYP3A-mediated drug-drug interactions. Antimicrob Agents Chemother. 63(5): e02016–e02018.
   PubMed Web of Science ®Google Scholar
• Kim SB, Yoon IS, Kim KS, Cho SJ, Kim YS, Cho HJ, Chung SJ, Chong S, Kim DD. 2014. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism. Planta Med. 80(07):561–567.
   PubMed Web of Science ®Google Scholar
• Kolars JC, Schmiedlin-Ren P, Dobbins WO, 3rd, Schuetz J, Wrighton SA, Watkins PB. 1992. Heterogeneity of cytochrome P450IIIA expression in rat gut epithelia. Gastroenterology. 102(4):1186–1198.
   PubMed Web of Science ®Google Scholar
• Komura H, Iwaki M. 2008. Species differences in in vitro and in vivo small intestinal metabolism of CYP3A substrates. J Pharm Sci. 97(5):1775–1800.
   PubMed Web of Science ®Google Scholar
• Kramer MA, Tracy TS. 2008. Studying cytochrome P450 kinetics in drug metabolism. Expert Opin Drug Metab Toxicol. 4(5):591–603.
   PubMed Web of Science ®Google Scholar
• Lagoa R, Silva J, Rodrigues JR, Bishayee A. 2020. Advances in phytochemical delivery systems for improved anticancer activity. Biotechnol Adv. 38:107382.
   PubMed Web of Science ®Google Scholar
• Lamba JK, Lin YS, Schuetz EG, Thummel KE. 2002. Genetic contribution to variable human CYP3A-mediated metabolism. Adv Drug Deliv Rev. 54(10):1271–1294.
   PubMed Web of Science ®Google Scholar
• Li HY, Xu W, Su J, Zhang X, Hu LW, Zhang WD. 2010. In vitro and in vivo inhibitory effects of glycyrrhetinic acid on cytochrome P450 3A activity. Pharmacology. 86(5–6):287–292.
   PubMed Web of Science ®Google Scholar
• Li M, Wang F, Huang Y, Du F, Zhong C, Olaleye OE, Jia W, Li Y, Xu F, Dong J, et al. 2015. Systemic exposure to and disposition of catechols derived from Salvia miltiorrhiza roots (Danshen) after intravenous dosing DanHong injection in human subjects, rats, and dogs. Drug Metab Dispos. 43(5):679–690.
   PubMed Web of Science ®Google Scholar
• Li WL, Xin HW, Su MW. 2012. Inhibitory effects of continuous ingestion of Schisandrin A on CYP3A in the rat. Basic Clin Pharmacol Toxicol. 110(2):187–192.
   PubMed Web of Science ®Google Scholar
• Li WL, Xin HW, Su MW, Xiong L. 2010. Inhibitory effects of schisandrin A and schisandrin B on CYP3A activity. Methods Find Exp Clin Pharmacol. 32(3):163–169.
   PubMedGoogle Scholar
• Li WL, Xin HW, Yu AR, Wu XC. 2013. In vivo effect of Schisandrin B on cytochrome P450 enzyme activity. Phytomedicine. 20(8–9):760–765.
   PubMed Web of Science ®Google Scholar
• Li Y, Qin J, Wu H, Xu Y, Zhang L, Su K, Cui Y, Wang H. 2020. In vitro inhibitory effect of lysionotin on the activity of cytochrome P450 enzymes. Pharm Biol. 58(1):695–700.
   PubMed Web of Science ®Google Scholar
• Lin JH, Lu AY. 2001. Interindividual variability in inhibition and induction of cytochrome P450 enzymes. Annu Rev Pharmacol Toxicol. 41(1):535–567.
   PubMed Web of Science ®Google Scholar
• Liu H, Yang J, Du F, Gao X, Ma X, Huang Y, Xu F, Niu W, Wang F, Mao Y, et al. 2009. Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats. Drug Metab Dispos. 37(12):2290–2298.
   PubMed Web of Science ®Google Scholar
• Liu L, Jiang Z, Liu J, Huang X, Wang T, Liu J, Zhang Y, Zhou Z, Guo J, Yang L, et al. 2010. Sex differences in subacute toxicity and hepatic microsomal metabolism of triptolide in rats. Toxicology. 271(1–2):57–63.
   PubMed Web of Science ®Google Scholar
• Liu YT, Hao HP, Liu CX, Wang GJ, Xie HG. 2007. Drugs as CYP3A probes, inducers, and inhibitors. Drug Metab Rev. 39(4):699–721.
   PubMed Web of Science ®Google Scholar
• Lou D, Bao SS, Li YH, Lin QM, Yang SF, He JY. 2019. Inhibitory mechanisms of myricetin on human and rat liver cytochrome P450 enzymes. Eur J Drug Metab Pharmacokinet. 44(5):611–618.
   PubMed Web of Science ®Google Scholar
• Lu T, Yang J, Gao X, Chen P, Du F, Sun Y, Wang F, Xu F, Shang H, Huang Y, et al. 2008. Plasma and urinary tanshinol from Salvia miltiorrhiza (Danshen) can be used as pharmacokinetic markers for cardiotonic pills, a cardiovascular herbal medicine. Drug Metab Dispos. 36(8):1578–1586.
   PubMed Web of Science ®Google Scholar
• Lu Y, Xie T, Zhang Y, Zhou F, Ruan J, Zhu W, Zhu H, Feng Z, Zhou X. 2017. Triptolide induces hepatotoxicity via inhibition of CYP450s in rat liver microsomes. BMC Complement Altern Med. 17(1):15.
   PubMed Web of Science ®Google Scholar
• Luo Z, Liu Y, Zhao B, Tang M, Dong H, Zhang L, Lv B, Wei L. 2013. Ex vivo and in situ approaches used to study intestinal absorption. J Pharmacol Toxicol Methods. 68(2):208–216.
   PubMed Web of Science ®Google Scholar
• Lv QL, Wang GH, Chen SH, Hu L, Zhang X, Ying G, Qin CZ, Zhou HH. 2015. In vitro and in vivo inhibitory effects of glycyrrhetinic acid in mice and human cytochrome P450 3A4. Int J Env Res Public Health. 13(1):84.
   PubMed Web of Science ®Google Scholar
• Ma BL, Ma YM. 2016. Pharmacokinetic herb-drug interactions with traditional Chinese medicine: progress, causes of conflicting results and suggestions for future research. Drug Metab Rev. 48(1):1–26.
   PubMed Web of Science ®Google Scholar
• Martignoni M, Groothuis G, de Kanter R. 2006. Comparison of mouse and rat cytochrome P450-mediated metabolism in liver and intestine.Drug Metab Dispos. 34(6):1047–1054.
   PubMed Web of Science ®Google Scholar
• Matsubara T, Kim HJ, Miyata M, Shimada M, Nagata K, Yamazoe Y. 2004. Isolation and characterization of a new major intestinal CYP3A form, CYP3A62, in the rat. J Pharmacol Exp Ther. 309(3):1282–1290.
   PubMed Web of Science ®Google Scholar
• Miron A, Aprotosoaie AC, Trifan A, Xiao J. 2017. Flavonoids as modulators of metabolic enzymes and drug transporters. Ann NY Acad Sci. 1398(1):152–167.
   PubMed Web of Science ®Google Scholar
• Morisaki T, Hou XL, Takahashi K, Takahashi K. 2013. Baicalin pharmacokinetic profile of absorption process using novel in-vitro model: cytochrome P450 3A4-induced Caco-2 cell monolayers combined with rat intestinal rinse fluids. J Pharm Pharmacol. 65(10):1526–1535.
   PubMed Web of Science ®Google Scholar
• Mulvihill EE, Burke AC, Huff MW. 2016. Citrus flavonoids as regulators of lipoprotein metabolism and atherosclerosis. Annu Rev Nutr. 36(1):275–299.
   PubMed Web of Science ®Google Scholar
• Neelam , Khatkar A, Sharma KK. 2020. Phenylpropanoids and its derivatives: biological activities and its role in food, pharmaceutical and cosmetic industries. Crit Rev Food Sci Nutr. 60(16):2655–2675.
   PubMed Web of Science ®Google Scholar
• Nguyen LT, Myslivečková Z, Szotáková B, Špičáková A, Lněničková K, Ambrož M, Kubíček V, Krasulová K, Anzenbacher P, Skálová L. 2017. The inhibitory effects of β-caryophyllene, β-caryophyllene oxide and α-humulene on the activities of the main drug-metabolizing enzymes in rat and human liver in vitro. Chem Biol Interact. 278:123–128.
   PubMed Web of Science ®Google Scholar
• Oostendorp RL, Huitema A, Rosing H, Jansen RS, Ter Heine R, Keessen M, Beijnen JH, Schellens JH. 2009. Coadministration of ritonavir strongly enhances the apparent oral bioavailability of docetaxel in patients with solid tumors. Clin Cancer Res. 15(12):4228–4233.
   PubMed Web of Science ®Google Scholar
• Östlund J, Zlabek V, Zamaratskaia G. 2017. In vitro inhibition of human CYP2E1 and CYP3A by quercetin and myricetin in hepatic microsomes is not gender dependent. Toxicology. 381(2017):10–18.
   PubMed Web of Science ®Google Scholar
• Paine MF, Hart HL, Ludington SS, Haining RL, Rettie AE, Zeldin DC. 2006. The human intestinal cytochrome P450 “pie”. Drug Metab Dispos. 34(5):880–886.
   PubMed Web of Science ®Google Scholar
• Paine MF, Khalighi M, Fisher JM, Shen DD, Kunze KL, Marsh CL, Perkins JD, Thummel KE. 1997. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. J Pharmacol Exp Ther. 283(3):1552–1562.
   PubMed Web of Science ®Google Scholar
• Pan RY, Ma J, Kong XX, Wang XF, Li SS, Qi XL, Yan YH, Cheng J, Liu Q, Jin W, et al. 2019. Sodium rutin ameliorates Alzheimer’s disease-like pathology by enhancing microglial amyloid-β clearance. Sci Adv. 5(2):eaau6328.
   PubMed Web of Science ®Google Scholar
• Peters SA, Jones CR, Ungell AL, Hatley OJ. 2016. Predicting drug extraction in the human gut wall: assessing contributions from drug metabolizing enzymes and transporter proteins using preclinical models. Clin Pharmacokinet. 55(6):673–696.
   PubMed Web of Science ®Google Scholar
• Qiu F, Jiang J, Ma Y, Wang G, Gao C, Zhang X, Zhang L, Liu S, He M, Zhu L, et al. 2013. Opposite effects of single-dose and multidose administration of the ethanol extract of danshen on CYP3A in healthy volunteers. Evid Based Complement Alternat Med. 2013:1–8.
   Web of Science ®Google Scholar
• Qiu F, Wang G, Zhang R, Sun J, Jiang J, Ma Y. 2010. Effect of danshen extract on the activity of CYP3A4 in healthy volunteers. Br J Clin Pharmacol. 69(6):656–662.
   PubMed Web of Science ®Google Scholar
• Quintieri L, Palatini P, Nassi A, Ruzza P, Floreani M. 2008. Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes. Biochem Pharmacol. 75(6):1426–1437.
   PubMed Web of Science ®Google Scholar
• Raunio H, Kuusisto M, Juvonen RO, Pentikäinen OT. 2015. Modeling of interactions between xenobiotics and cytochrome P450 (CYP) enzymes. Front Pharmacol. 6:123.
   PubMed Web of Science ®Google Scholar
• Rezaee MM, Kazemi S, Kazemi MT, Gharooee S, Yazdani E, Gharooee H, Shiran MR, Moghadamnia AA. 2014. The effect of piperine on midazolam plasma concentration in healthy volunteers, a research on the CYP3A-involving metabolism. Daru. 22(1):8.
   PubMed Web of Science ®Google Scholar
• Rouf R, Uddin SJ, Sarker DK, Islam MT, Ali ES, Shilpi JA, Nahar L, Tiralongo E, Sarker SD. 2020. Antiviral potential of garlic (Allium sativum) and its organosulfur compounds: a systematic update of pre-clinical and clinical data. Trends Food Sci Technol. 104(2020):219–234.
   PubMed Web of Science ®Google Scholar
• Salphati L, Childers K, Pan L, Tsutsui K, Takahashi L. 2010. Evaluation of a single-pass intestinal-perfusion method in rat for the prediction of absorption in man. J Pharm Pharmacol. 53(7):1007–1013.
   Web of Science ®Google Scholar
• Scandlyn MJ, Stuart EC, Rosengren RJ. 2008. Sex-specific differences in CYP450 isoforms in humans. Expert Opin Drug Met. 4(4):413–424.
   PubMed Web of Science ®Google Scholar
• Schuetz JD, Beach DL, Guzelian PS. 1994. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics. 4(1):11–20.
   PubMedGoogle Scholar
• Scott EE, Halpert JR. 2005. Structures of cytochrome P450 3A4. Trends Biochem Sci. 30(1):5–7.
   PubMed Web of Science ®Google Scholar
• Sevrioukova IF, Poulos TL. 2012. Structural and mechanistic insights into the interaction of cytochrome P4503A4 with bromoergocryptine, a type I ligand. J Biol Chem. 287(5):3510–3517.
   PubMed Web of Science ®Google Scholar
• Sevrioukova IF, Poulos TL. 2013. Understanding the mechanism of cytochrome P450 3A4: recent advances and remaining problems. Dalton Trans. 42(9):3116–3126.
   PubMed Web of Science ®Google Scholar
• Sevrioukova IF, Poulos TL. 2017. Structural basis for regiospecific midazolam oxidation by human cytochrome P450 3A4. Proc Natl Acad Sci USA. 114(3):486–491.
   PubMed Web of Science ®Google Scholar
• Shen G, Zhuang X, Xiao W, Kong L, Tan Y, Li H. 2014. Role of CYP3A in regulating hepatic clearance and hepatotoxicity of triptolide in rat liver microsomes and sandwich-cultured hepatocytes. Food Chem Toxicol. 71:90–96.
   PubMed Web of Science ®Google Scholar
• Shi F, Pan H, Cui B, Li Y, Huang L, Lu Y. 2019. Dictamnine-induced hepatotoxicity in mice: the role of metabolic activation of furan. Toxicol Appl Pharmacol. 364(2019):68–76.
   PubMed Web of Science ®Google Scholar
• Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. 1994. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther. 270(1):414–423.
   PubMed Web of Science ®Google Scholar
• Song M, Hong M, Lee MY, Jee JG, Lee YM, Bae JS, Jeong TC, Lee S. 2013. Selective inhibition of the cytochrome P450 isoform by hyperoside and its potent inhibition of CYP2D6. Food Chem Toxicol. 59(2013):549–553.
   PubMed Web of Science ®Google Scholar
• Stappaerts J, Brouwers J, Annaert P, Augustijns P. 2015. In situ perfusion in rodents to explore intestinal drug absorption: challenges and opportunities. Int J Pharm. 478(2):665–681.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Taniyama K, Aoyama T, Watanabe Y. 2020. Bergamottin can be used to assess CYP3A-mediated intestinal first-pass metabolism without affecting P-glycoprotein-mediated efflux in rats. Xenobiotica. 50(4):401–407.
   PubMed Web of Science ®Google Scholar
• Tateishi T, Watanabe M, Moriya H, Yamaguchi S, Sato T, Kobayashi S. 1999. No ethnic difference between Caucasian and Japanese hepatic samples in the expression frequency of CYP3A5 and CYP3A7 proteins. Biochem Pharmacol. 57(8):935–939.
   PubMed Web of Science ®Google Scholar
• Thummel KE, Wilkinson GR. 1998. In vitro and in vivo drug interactions involving human CYP3A. Annu Rev Pharmacol Toxicol. 38(1):389–430.
   PubMed Web of Science ®Google Scholar
• Tian QQ, Zhu YT, Diao XX, Zhang XL, Xu YC, Jiang XR, Shen JS, Wang Z, Zhong DF. 2021. Species differences in the CYP3A-catalyzed metabolism of TPN729, a novel PDE5 inhibitor. Acta Pharmacol Sin. 42(3):482–490.
   PubMed Web of Science ®Google Scholar
• Tian X, Cheng ZY, He J, Jia LJ, Qiao HL. 2013. Concentration-dependent inhibitory effects of baicalin on the metabolism of dextromethorphan, a dual probe of CYP2D and CYP3A, in rats. Chem Biol Interact. 203(2):522–529.
   PubMed Web of Science ®Google Scholar
• Tian X, Cheng ZY, Jin H, Gao J, Qiao HL. 2013. Inhibitory effects of baicalin on the expression and activity of CYP3A induce the pharmacokinetic changes of midazolam in rats. Evid Based Complement Alternat Med. 2013:1–10.
   Web of Science ®Google Scholar
• Tian Y, Shen S, Jiang Y, Shen Q, Zeng S, Zheng J. 2016. CYP3A5 mediates bioactivation and cytotoxicity of tetrandrine. Arch Toxicol. 90(7):1737–1748.
   PubMed Web of Science ®Google Scholar
• Umathe SN, Dixit PV, Kumar V, Bansod KU, Wanjari MM. 2008. Quercetin pretreatment increases the bioavailability of pioglitazone in rats: involvement of CYP3A inhibition. Biochem Pharmacol. 75(8):1670–1676.
   PubMed Web of Science ®Google Scholar
• van Herwaarden AE, van Waterschoot RA, Schinkel AH. 2009. How important is intestinal cytochrome P450 3A metabolism? Trends Pharmacol Sci. 30(5):223–227.
   PubMed Web of Science ®Google Scholar
• van Waterschoot RA, Schinkel AH. 2011. A critical analysis of the interplay between cytochrome P450 3A and P-glycoprotein: recent insights from knockout and transgenic mice. Pharmacol Rev. 63(2):390–410.
   PubMed Web of Science ®Google Scholar
• Vidoni C, Ferraresi A, Secomandi E, Vallino L, Dhanasekaran DN, Isidoro C. 2020. Epigenetic targeting of autophagy for cancer prevention and treatment by natural compounds. Semin Cancer Biol. 66:34–44.
   PubMed Web of Science ®Google Scholar
• von Moltke LL, Weemhoff JL, Bedir E, Khan IA, Harmatz JS, Goldman P, Greenblatt DJ. 2010. Inhibition of human cytochromes P450 by components of Ginkgo biloba. J Pharm Pharmacol. 56(8):1039–1044.
   Web of Science ®Google Scholar
• Wang J, Liang Q, Ji L, Liu H, Wang C, Wang Z. 2011. Gender-related difference in liver injury induced by Dioscorea bulbifera L. rhizome in mice. Hum Exp Toxicol. 30(9):1333–1341.
   PubMed Web of Science ®Google Scholar
• Wang K, Gao Q, Zhang T, Rao J, Ding L, Qiu F. 2020. Inhibition of CYP2C9 by natural products: insight into the potential risk of herb-drug interactions. Drug Metab Rev. 52(2):235–257.
   PubMed Web of Science ®Google Scholar
• Wang X, Lee WY, Zhou X, Or PM, Yeung JH. 2010. A pharmacodynamic-pharmacokinetic (PD-PK) study on the effects of Danshen (Salvia miltiorrhiza) on midazolam, a model CYP3A probe substrate, in the rat. Phytomedicine. 17(11):876–883.
   PubMed Web of Science ®Google Scholar
• Wang X, Qiao Z, Liu J, Zheng M, Liu W, Wu C. 2018. Stereoselective in vitro metabolism of rhynchophylline and isorhynchophylline epimers of Uncaria rhynchophylla in rat liver microsomes. Xenobiotica. 48(10):990–998.
   PubMed Web of Science ®Google Scholar
• Wang X, Yeung JH. 2011. Inhibitory effect of tanshinones on rat CYP3A2 and CYP2C11 activity and its structure-activity relationship. Fitoterapia. 82(4):539–545.
   PubMed Web of Science ®Google Scholar
• Weathers PJ, Elfawal MA, Towler MJ, Acquaah-Mensah GK, Rich SM. 2014. Pharmacokinetics of artemisinin delivered by oral consumption of Artemisia annua dried leaves in healthy vs. Plasmodium chabaudi-infected mice. J Ethnopharmacol. 153(3):732–736.
   PubMed Web of Science ®Google Scholar
• Weathers PJ, Towler M, Hassanali A, Lutgen P, Engeu PO. 2014. Dried-leaf Artemisia annua: a practical malaria therapeutic for developing countries? WJP. 3(4):39–55.
   Google Scholar
• Williams PA, Cosme J, Vinkovic DM, Ward A, Angove HC, Day PJ, Vonrhein C, Tickle IJ, Jhoti H. 2004. Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone. Science. 305(5684):683–686.
   PubMed Web of Science ®Google Scholar
• Wrighton SA, Brian WR, Sari MA, Iwasaki M, Guengerich FP, Raucy JL, Molowa DT, Vandenbranden M. 1990. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol Pharmacol. 38(2):207–213.
   PubMed Web of Science ®Google Scholar
• Wu J, Cao Y, Zhang Y, Liu Y, Hong JY, Zhu L, Ge G, Yang L. 2014. Deoxyschizandrin, a naturally occurring lignan, is a specific probe substrate of human cytochrome P450 3A. Drug Metab Dispos. 42(1):94–104.
   PubMed Web of Science ®Google Scholar
• Wu L, Zhong W, Liu J, Han W, Zhong S, Wei Q, Liu S, Tang L. 2015. Human microsomal cyttrochrome P450-mediated reduction of oxysophocarpine, an active and highly toxic constituent derived from Sophora flavescens species, and its intestinal absorption and metabolism in rat. Fitoterapia. 105:26–36.
   PubMed Web of Science ®Google Scholar
• Xia C, Sun J, Wang G, Shang L, Zhang X, Zhang R, Wang X, Hao H, Xie L. 2009. Differential effect of Shenmai injection, a herbal preparation, on the cytochrome P450 3A-mediated 1'-hydroxylation and 4-hydroxylation of midazolam. Chem Biol Interact. 180(3):440–448.
   PubMed Web of Science ®Google Scholar
• Xin HW, Wu XC, Li Q, Yu AR, Xiong L. 2009. Effects of Schisandra sphenanthera extract on the pharmacokinetics of midazolam in healthy volunteers. Br J Clin Pharmacol. 67(5):541–546.
   PubMed Web of Science ®Google Scholar
• Xu S, Zhang F, Chen D, Su K, Zhang L, Jiang R. 2020. In vitro inhibitory effects of ganoderic acid A on human liver cytochrome P450 enzymes. Pharm Biol. 58(1):308–313.
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhang YF, Chen XY, Zhong DF. 2018. CYP3A4 inducer and inhibitor strongly affect the pharmacokinetics of triptolide and its derivative in rats. Acta Pharmacol Sin. 39(8):1386–1392.
   PubMed Web of Science ®Google Scholar
• Yang B, Liu W, Chen K, Wang Z, Wang C. 2014. Metabolism of diosbulbin B in vitro and in vivo in rats: formation of reactive metabolites and human enzymes involved. Drug Metab Dispos. 42(10):1737–1750.
   PubMed Web of Science ®Google Scholar
• Yang B, Wang X, Liu W, Zhang Q, Chen K, Ma Y, Wang C, Wang Z. 2013. Gender-related pharmacokinetics and absolute bioavailability of diosbulbin B in rats determined by ultra-performance liquid chromatography-tandem mass spectrometry. J Ethnopharmacol. 149(3):810–815.
   PubMed Web of Science ®Google Scholar
• Yang L, Wang Y, Huang G, Li J, Zhang Z, Ma Z, Gao Y. 2018. Simultaneous evaluation of the influence of Panax ginseng on the pharmacokinetics of three diester alkaloids after oral administration of Aconiti lateralis radix in Rats Using UHPLC/QQQ-MS/MS. Evid Based Complement Alternat Med. 2018:1–14.
   Web of Science ®Google Scholar
• Yang L, Wang Y, Xu H, Huang G, Zhang Z, Ma Z, Gao Y. 2019. Panax ginseng inhibits metabolism of diester alkaloids by downregulating CYP3A4 enzyme activity via the pregnane X receptor. Evid Based Complement Alternat Med. 2019:1–13.
   Web of Science ®Google Scholar
• Yang X, Zhang B, Molony C, Chudin E, Hao K, Zhu J, Gaedigk A, Suver C, Zhong H, Leeder JS, et al. 2010. Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver. Genome Res. 20(8):1020–1036.
   PubMed Web of Science ®Google Scholar
• Yang XF, Wang NP, Lu WH, Zeng FD. 2003. Effects of Ginkgo biloba extract and tanshinone on cytochrome P-450 isozymes and glutathione transferase in rats. Acta Pharmacol Sin. 24(10):1033–1038.
   PubMed Web of Science ®Google Scholar
• Yazaki K, Arimura GI, Ohnishi T. 2017. ‘Hidden’ terpenoids in plants: their biosynthesis, localization and ecological roles. Plant Cell Physiol. 58(10):1615–1621.
   PubMed Web of Science ®Google Scholar
• Yim D, Kim MJ, Shin Y, Lee SJ, Shin JG, Kim DH. 2019. Inhibition of cytochrome P450 activities by Sophora flavescens extract and its prenylated flavonoids in human liver microsomes. Evid Based Complement Alternat Med. 2019:1–10.
   Web of Science ®Google Scholar
• Yu CP, Wu PP, Hou YC, Lin SP, Tsai SY, Chen CT, Chao PD. 2011. Quercetin and rutin reduced the bioavailability of cyclosporine from Neoral, an immunosuppressant, through activating P-glycoprotein and CYP 3A4. J Agric Food Chem. 59(9):4644–4648.
   PubMed Web of Science ®Google Scholar
• Zeng C, He F, Xia C, Zhang H, Xiong Y. 2013. Identification of the active components in Shenmai injection that differentially affect Cyp3a4-mediated 1'-hydroxylation and 4-hydroxylation of midazolam. Drug Metab Dispos. 41(4):785–790.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yan R, Su R, Yang C, Liu S, Yu X, Chang X, Zhang S, Liu C, Xu M, et al. 2014. Bioavailability enhancement of osthole after oral administration of Bushen Yizhi prescription extract to rats followed by Cnidium monnieri (L.) Cusson fruits extract in comparison to pure osthole at different doses. J Ethnopharmacol. 152(2):266–271.
   PubMed Web of Science ®Google Scholar
• Zhang M, Peng CS, Li XB. 2017. Human intestine and liver microsomal metabolic differences between C19-diester and monoester diterpenoid alkaloids from the roots of Aconitum carmichaelii Debx. Toxicol in Vitro. 45(3):318–333.
   PubMed Web of Science ®Google Scholar
• Zhang SJ, Luo D, Li L, Tan RR, Xu QQ, Qin J, Zhu L, Luo NC, Xu TT, Zhang M, et al. 2017. Ethyl acetate extract components of Bushen-Yizhi formula provides neuroprotection against scopolamine-induced cognitive impairment. Sci Rep. 7(1):9824.
   PubMed Web of Science ®Google Scholar
• Zhang W, Guo J, Wang D, Ren S, Hua H, Morikawa T, Pan Y, Liu X. 2020. Effect of CYP3A inducer/inhibitor on pharmacokinetics of five alkaloids in Evodiae fructus. Chem Biol Interact. 327:109146.
   PubMed Web of Science ®Google Scholar
• Zhang X, Feng P, Gao X, Wang B, Gou C, Bian R. 2020. In vitro inhibitory effects of cepharanthine on human liver cytochrome P450 enzymes. Pharm Biol. 58(1):247–252.
   PubMed Web of Science ®Google Scholar
• Zhao J, Sun T, Wu JJ, Cao YF, Fang ZZ, Sun HZ, Zhu ZT, Yang K, Liu YZ, Gonzalez FJ, et al. 2017. Inhibition of human CYP3A4 and CYP3A5 enzymes by gomisin C and gomisin G, two lignan analogs derived from Schisandra chinensis. Fitoterapia. 119:26–31.
   PubMed Web of Science ®Google Scholar
• Zhao J, Yang J, Xie Y. 2019. Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: an overview. Int J Pharm. 570(2019):118642.
   PubMed Web of Science ®Google Scholar
• Zhou SF. 2008. Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. CDM. 9(4):310–322.
   Web of Science ®Google Scholar
• Zhou Y, Hua A, Zhou Q, Geng P, Chen F, Yan L, Wang S, Wen C. 2020. Inhibitory effect of lygodium root on the cytochrome P450 3A enzyme in vitro and in vivo. DDDT. 14:1909–1919.
   PubMed Web of Science ®Google Scholar
• Zhu B, Liu ZQ, Chen GL, Chen XP, Ou-Yang DS, Wang LS, Huang SL, Tan ZR, Zhou HH. 2003. The distribution and gender difference of CYP3A activity in Chinese subjects. Brit J Clin Pharmaco. 55(3):264–269.
   PubMed Web of Science ®Google Scholar